In order to meet the daily production and analysis and testing, the company has invested a total of 30 million research and development funds, purchased 60 sets of key production equipment and analysis and testing equipment, and built a standardized synthesis laboratory of 2000 square meters. Under the efficient operation of the complete production and analysis equipment and the complete CDMO production workshop, the company has completed the scale-up production of several key intermediates for new drugs, such as Fapiravir, acatinib and entativir, and has become one of the main suppliers of key intermediates for many pyrazine new drugs.
In the process of development has been to product quality management as the first priority, has gradually established and improve the quality management system, the company has obtained ISO9001:2015 quality system certification. And in the development of continuous increase in analytical instruments, equipment purchase and personnel training and other aspects of investment to improve detection technology, improve detection indicators.
It plays an important role in the research and development stage of innovative drugs, and can serve customers to complete various basic research work and establish research databases. We strictly control the quality and schedule to provide domestic and foreign customers with intermediates required for new drug synthesis, which can achieve production from milligram level to tonnage level.
Scan code attention
